Rancho Santa Fe Bio
Daniel Bloomfield, MD/DPHIL, is an Interventional Cardiologist, Chief Medical Officer for Anthos Therapeutics, Inc., and former Senior VP, Global Chemical Development at Merck.
An Oxford Rhodes Scholar and Cardiologist, Dr. Bloomfield's career spans years of effective collaboration across a worldwide organization, partnership with the FDA, and most recently programmatic strategy in China across therapeutic areas, leading development programs to completion.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Rancho Santa Fe Bio
Rancho Santa Fe Bio develops cardiovascular drugs to slow the progression of calcification in patients with aortic valve stenosis.